静脉用药不良反应与药液中不溶性微粒数量相关性的初步分析

南方医科大学学报 ›› 2004, Vol. 24 ›› Issue (01): 24-26.

静脉用药不良反应与药液中不溶性微粒数量相关性的初步分析

汪艳, 王桂芳, 叶海英

第一军医大学珠江医院药剂科, 广东, 广州, 510282

出版日期:2004-01-20 发布日期:2004-01-20
基金资助:
收稿日期:2003-4-7。
基金项目:广东省医学科研基金(A2003471)
作者简介:汪艳(1973- ),女,1994年毕业于第一军医大学,博士,主管药师,电话:020-61643555,E-mail:yilan999@hotmail.com

Analysis of the association between the quantity of insoluble particles in intravenously admin-istered solution with adverse drug reactions

WANG Yan, WANG Gui-fang, YE Hai-ying

第一军医大学珠江医院药剂科, 广东, 广州, 510282

Online:2004-01-20 Published:2004-01-20

摘要/Abstract

摘要： 目的探讨静脉用药不良反应与有关不溶性微粒数量的相关性。方法模拟临床输液配制操作过程,对本院临床常用药配伍,测定进入病人静脉前液体不溶性微粒的数量。结果经输液器后不溶性微粒的数量均未超过中国药典中规定的相应标准。结论本院绝大部分输液药物不良反应可排除由于中国药典规定的有关微粒数量超标而引起的可能性。

Abstract: Objective To investigate th e possible association between adverse drug reactions and the quantity of insolu ble par-ticles in the intravenously administred drugs.Methods The solutions wer e prepared following the procedures in routine clini-cal practice, and the quant ity of insoluble particles in these solutions were measured before and after the solutions went through the transfusion apparatus.Results The quantity of inso luble particles measured after the solutions passed through the transfu-sion app aratus was consistent with the standard documented in Chinese Pharmacopoeia.Conclusion Adverse intravenous re-actions occurring in our hospital has no associat ion with excessive quantity of insoluble particles in the administered drugs.

中图分类号:

R917

汪艳, 王桂芳, 叶海英. 静脉用药不良反应与药液中不溶性微粒数量相关性的初步分析[J]. 南方医科大学学报, 2004, 24(01): 24-26.

WANG Yan, WANG Gui-fang, YE Hai-ying. Analysis of the association between the quantity of insoluble particles in intravenously admin-istered solution with adverse drug reactions[J]. Journal of Southern Medical University, 2004, 24(01): 24-26.

参考文献

[1] 李革晖,苏佳,伊丽.367例输液反应回顾性分析[J].药物流行病学杂志,2000,9(4):185-6.Li GH,Su J,YiL.Retrospective analysisofinfusion reaction-A 367case report[J].Chin J Pharmacoepidemiol,2000,9(4):185-6.
[2] 张延雪,王唯唯,周群.输液中联合用药引起输液反应原因探讨[J].西北药学杂志,2003,18(2):74-5.Zhang YX,Wang WW,Zhou QJ. Discussion of the reasons for infusion reaction after combination dosages of intravenous medicine[J].Northwest Pharm J,2003,18(2):74-5.
[3] 汪艳,胡东武,古维新,等.我院药物不良监察工作的实施与探讨[J].第一军医大学学报,2000,20(4):265-6.Wang Y,Hu DW,Gu WX,et al. The development of ADR surveillance in Zhujiang Hospital[J]. J First Mil Med Univ,2000,20(4):265-6.
[4] 林劲秋,李亚洁.维生素及其临床营养治疗[J].第一军医大学学报,2001,2l(12):947-50.Lin JQ,Li YJ. Vitamins and their clinical nutrition therapy[J]. J First Mil Med Univ,2001,21(12):947-50.
[5] 汤韧,张宜,傅立波.注射剂配伍后不同粒径不溶性微粒的倍增现象[J].中国医院药学杂志,1999,19(11):663-6.Tang R,Zhang Y,Fu LB,et al. The multiplication of particulate matter in injections mixed for administrations[J]. Chin J Hos Pharm,1999,19(11):663-6.
[6] 吴雪梅,钟智.中草药针剂与输液配伍的不溶性微粒考察[J].中国医院药学杂志,1999,19(2):81-3.Wu XM,Zhong Z. Investigation of particulate matter in traditional Chinese medicinal herbal injection mixed with transfusion[J]. Chin J Hos Pharm,1999,19(2):81-3.
[7] 梅丹,李大魁,张继春,等.静脉滴注用抗生素粉针剂中不溶性微粒考察[J] 中国药学杂志,1999,34(10):670-2.Mei D,Li DK,Zhang JC,et al. Determination of particulate matter after reconstituting antibioties in NS by Coulter counter[J]. Chin Pharm J,1999,34(10):670-2.
[8] 徐静,关英双黄连注射液致肺水肿1例报告[J].第一军医大学学报,2002,22(10):914Xu J,Guan Y. Pulmonary edema due to Shuanghuanglian injection:report of one case[J]. J First Mil Med Univ,2002,22(10):914.
[9] 李湘梅双黄连粉针剂与输液配伍后不溶性微粒号察[J].西北药学杂志,2001,16(4):191-2 Li XM. Determination of particles after reconstitution of Shuanghuanglian injection mixed with transfusion[J]. Northwest Pharm J,2001,16(4):191-2.
[10] 王华生,宋婉丽药液注射过滤器在临床上的应用[J].中华医院感染学杂志,2000.10(5):378-9.Wang HS,Song WL. The clinical use of medicine infusion strainer[J]. Chin J Nosoco Moil,2000,10(5):378-9.